Close Menu

NEW YORK – Roche said on Tuesday it has commenced a tender offer to purchase for cash a combined aggregate purchase price of up to $2 billion of certain notes.

The notes being purchased include 7 percent notes due 2039; 3.35 percent notes due 2024; 3.25 percent notes due 2023; 3 percent notes due 2025; 2.875 percent notes due 2021; and 5.25 percent senior notes due 2035. All notes are being offered by Roche except the 5.25 percent notes due 2035, which are being issued by Roche subsidiary Genentech.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.